Research article · 15 Apr 2026
Conference abstractPublished 26 Jun 2014
Diagnostic potential of natriuretic peptides in patients with impaired kidney function
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
P lasma B-type natriuretic peptide (BNP) and N-terminal proBNP (NT-proBNP) are heart failure (HF) markers and also rise in chronic kidney disease (CKD), but the effect of these biomarkers is not fully understood in CKD patients. The aim of this study was to determine BNP and NT-proBNP cutoffs predictable of HF in CKD cohort and compare its concentration in different stages of CKD. Adults with estimated glomerular filtration rate <60 ml/min for ≥3 months were identified in consulting clinics from June 2009 to March 2010. HF was defined as documented by a cardiologist with ejection fraction <40% and assessed by New York Heart Association classification (NYHA). A total of 190 subjects were enrolled in the study, 95 with and 95 without HF. The mean age of patients was 58 (±15) years, 67.4% being males. Mean BNP levels showed a 2.5 fold and 1.5 fold rise from CKD stage 3 to stage 5 in patients with and without HF respectively. NT-proBNP levels in non-HF group were 3 fold higher in CKD stage 5 compared to stage 3. Mean NT-proBNP levels were 4 fold higher in CKD stage 5 compared to stage 3 in patients with HF. Optimal BNP and NT-proBNP cutoffs for HF diagnosis for the entire CKD group were 300 pg/ mL and 4502 pg/mL respectively. BNP and NT-proBNP were elevated in patients with impaired kidney function even in the absence of HF and further increased stepwise with NYHA severity. However the magnitude of increase in NT-proBNP was greater than that of BNP.
Subjects
Nephrology & UrologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Journal of Nephrology & Therapeutics.
Brief report · 30 Mar 2026
Renal Fibrosis: Targeting Pathways For New Therapies
Brief report · 30 Mar 2026
SGLT2 Inhibitors: A New Era for Diabetic Kidney Disease
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Nephrology & Therapeutics
- SubjectNephrology & Urology
- BylineArticles whose byline prints “Lena Jafri”
